Regarding the T2D-related parameters, mean HbA1c was 6.8 ± 0.7%, and about half of the subjects had been receiving DPP-4 inhibitors, while about 40% of the subjects had not been taking any glucose-lowering agents at baseline. The gene discussed is DPP4; the disease is type 2 diabetes mellitus.